How Do You Holistically Manage Triglycerides and HDL for Cardiorenal Metabolic Syndrome?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
How Do You Holistically Manage Triglycerides and HDL for Cardiorenal Metabolic Syndrome?
-
ナレーター：
-
著者：
このコンテンツについて
Join Drs Nihar Desai and Pam Taub as they discuss the nuances involved in understanding and managing triglycerides and HDL for cardiorenal metabolic syndrome.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999846. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A State-of-the-Art Review https://pubmed.ncbi.nlm.nih.gov/38103820/
The Association Between Triglycerides and Incident Cardiovascular Disease: What Is "Optimal"? https://pubmed.ncbi.nlm.nih.gov/32571728/
Helsinki Heart Study: Primary-Prevention Trial With Gemfibrozil in Middle-Aged Men With Dyslipidemia. Safety of Treatment, Changes in Risk Factors, and Incidence of Coronary Heart Disease https://pubmed.ncbi.nlm.nih.gov/3313041/
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/20228404/
Triglyceride Lowering With Pemafibrate to Reduce Cardiovascular Risk https://pubmed.ncbi.nlm.nih.gov/36342113/
Apolipoprotein B https://emedicine.medscape.com/article/2087335-overview
Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia https://pubmed.ncbi.nlm.nih.gov/30415628/
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/33190147/
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia https://pubmed.ncbi.nlm.nih.gov/38804517/
PCSK9 Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK448100/
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee https://pubmed.ncbi.nlm.nih.gov/34332805/
Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial https://pubmed.ncbi.nlm.nih.gov/39221651/
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/37807924/